B & T Capital Management Dba Alpha Capital Management Crispr Therapeutics Ag Transaction History

B & T Capital Management Dba Alpha Capital Management

$500 Million
Q1 2025

A detailed history of B & T Capital Management Dba Alpha Capital Management transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, B & T Capital Management Dba Alpha Capital Management holds 12,223 shares of CRSP stock, worth $543,067. This represents 0.08% of its overall portfolio holdings.

Number of Shares

12,223

Holding current value

$543,067

% of portfolio

0.08%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	BUY	$34.03 - $53.02 $415,948 - $648,063	12,223 New	12,223 $415,000
Q2 2024 Jul 18, 2024	SELL	$51.17 - $68.18 $389,403 - $518,849	-7,610 Reduced 17.2%	36,636 $1.98 Million
Q1 2024 Apr 12, 2024	SELL	$60.67 - $89.12 $29,849 - $43,847	-492 Reduced 1.1%	44,246 $3.02 Million
Q4 2023 Jan 17, 2024	SELL	$38.62 - $72.18 $54,492 - $101,845	-1,411 Reduced 3.06%	44,738 $2.8 Million
Q3 2023 Oct 17, 2023	BUY	$45.39 - $59.0 $599,511 - $779,272	13,208 Added 40.1%	46,149 $2.09 Million
Q4 2022 Feb 06, 2023	BUY	$39.19 - $65.67 $110,633 - $185,386	2,823 Added 9.37%	32,941 $1.34 Million
Q3 2022 Oct 13, 2022	BUY	$61.1 - $83.78 $196,314 - $269,185	3,213 Added 11.94%	30,118 $1.97 Million
Q2 2022 Jul 26, 2022	BUY	$43.23 - $73.83 $154,806 - $264,385	3,581 Added 15.35%	26,905 $1.64 Million
Q1 2022 Apr 28, 2022	BUY	$53.19 - $79.24 $45,317 - $67,512	852 Added 3.79%	23,324 $1.46 Million
Q4 2021 Jan 18, 2022	SELL	$70.09 - $111.29 $169,547 - $269,210	-2,419 Reduced 9.72%	22,472 $1.7 Million
Q3 2021 Nov 01, 2021	SELL	$110.2 - $156.64 $62,703 - $89,128	-569 Reduced 2.23%	24,891 $2.79 Million
Q2 2021 Jul 23, 2021	BUY	$100.84 - $161.89 $1.73 Million - $2.77 Million	17,118 Added 205.2%	25,460 $4.12 Million
Q1 2021 May 03, 2021	BUY	$110.72 - $210.04 $350,318 - $664,566	3,164 Added 61.1%	8,342 $1.02 Million
Q4 2020 Feb 02, 2021	BUY	$79.67 - $173.23 $412,531 - $896,984	5,178 New	5,178 $793,000

Others Institutions Holding CRSP

# of Institutions

480

Shares Held

64.2M

Call Options Held

2.15M

Put Options Held

1.92M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.47B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of B & T Capital Management Dba Alpha Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on B & T Capital Management Dba Alpha Capital Management with notifications on news.

Account

B & T Capital Management Dba Alpha Capital Management Crispr Therapeutics Ag Transaction History